Showing results (601-610 of 1,615) with videos related to
Sort By:
Pageof 162
Cancer Journal (Sudbury, Mass.)|July 22, 2017
The Biology of Aging and Cancer: Frailty, Inflammation, and ImmunityXinwen Zhang, Xin Meng, Yiyin Chen, et al.Cancer Journal (Sudbury, Mass.)|July 22, 2017
Geriatric Assessment and Tools for Predicting Treatment Toxicity in Older Adults With CancerDaneng Li, Enrique Soto-Perez-de-Celis, Arti HurriaCancer Journal (Sudbury, Mass.)|July 22, 2017
The Impact of Polypharmacy on Patient Outcomes in Older Adults With CancerGinah Nightingale, Emily Skonecki, Manpreet K BoparaiCancer Journal (Sudbury, Mass.)|June 25, 2016
Biomarker in Colorectal CancerMarta Schirripa, Heinz-Josef LenzCancer Journal (Sudbury, Mass.)|June 25, 2016
Therapeutic Approaches to RAS MutationAaron J Scott, Christopher H Lieu, Wells A MessersmithCancer Journal (Sudbury, Mass.)|June 25, 2016
BRAF-Directed Therapy in Metastatic Colorectal CancerKrittiya Korphaisarn, Scott KopetzCancer Journal (Sudbury, Mass.)|June 25, 2016
Immunotherapy Progress in Mismatch Repair-Deficient Colorectal Cancer and Future Therapeutic ChallengesJames T Link, Michael James OvermanCancer Journal (Sudbury, Mass.)|June 25, 2016
Vitamin D and Physical Activity in Patients With Colorectal Cancer: Epidemiological Evidence and Therapeutic ImplicationsVicente Morales-Oyarvide, Jeffrey A Meyerhardt, Kimmie NgCancer Journal (Sudbury, Mass.)|June 25, 2016
Value in Colorectal Cancer Treatment: Where It Is Lacking, and WhyLeonard B SaltzCancer Journal (Sudbury, Mass.)|September 22, 2015
Trastuzumab Emtansine (T-DM1) in Patients With HER2-Positive Metastatic Breast Cancer Previously Treated With Chemotherapy and 2 or More HER2-Targeted Agents: Results From the T-PAS Expanded Access StudyDenise A Yardley, Ian E Krop, Patricia M LoRusso, et al.Pageof 162